Objective: To investigate the feasibility and short-term safety of robotic assisted gastrectomy (RAG) for the treatment of gastric cancer. Methods: The clinical data of 235 gastric cancer patients undergoing radical gastrectomy between January 2017 and February 2018 were retrospectively analyzed. Of the patients, 100 cases underwent RAG and 135 cases underwent laparoscopic- assisted gastrectomy (LAG). The relevant clinical variable between the two groups of patients were compared. Results: The demographic characteristics and clinicopathological features were matched between the two groups. Either in the entire group or in the subgroups stratified by BMI, resection type and age, the length of hospitalization was reduced, time to first anal gas passage was shortened, and the number of dissected lymph nodes was increased in RAG group compared with LAG group (all P<0.05). Further analyses showed that the increased number of dissected lymph nodes in RAG group mainly depended on the increased average numbers of dissected lymph nodes in No. 6, 7, 10, 11p and 14v lymph nodes (all P<0.05). There was no significant difference between the two groups in terms of operative time, surgical bleeding, time to liquid diet and incidence of postoperative complications (all P>0.05). Conclusion: RAG is a safe and feasible method for the treatment of gastric cancer, but its long-term results and prognosis still need to be verified by further studies.